Acquiring Company
Esteve
Acquired Company
Sanofi
BarcelonaManufacturingBiotechnologyHealth CarePharmaceuticalBiotechnologyHealth CareMedicalPharmaceuticalDescription
Esteve Pharmaceuticals has acquired global rights to Caprelsa® (vandetanib) from Sanofi. This acquisition strengthens Esteve's position in the rare oncology market, particularly for medullary thyroid carcinoma, a disease with limited treatment options. Esteve aims to leverage its existing portfolio and clinical expertise to enhance market entry and reduce costs for the new therapy. The deal aligns with Esteve's strategy of focusing on niche markets and rare therapies.
Who to call at Esteve, and when
When Esteve changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Esteve raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Esteve, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Esteve. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Esteve makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Sanofi?
Sanofi was acquired by Esteve, based in Barcelona. The deal was reported on July 1, 2025. Esteve is a global pharmaceutical company headquartered in Barcelona, focused on providing solutions for unmet medical needs. Esteve is privately held and operates in Manufacturing.
When did Esteve acquire Sanofi?
Esteve's acquisition of Sanofi was reported on July 1, 2025. Esteve Pharmaceuticals has acquired global rights to Caprelsa® (vandetanib) from Sanofi. This acquisition strengthens Esteve's position in the rare oncology market, particularly for medullary thyroid carcinoma, a disease with limited treatment options. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sanofi do?
It is publicly traded (SNY), operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.